JPWO2019219831A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019219831A5
JPWO2019219831A5 JP2021514483A JP2021514483A JPWO2019219831A5 JP WO2019219831 A5 JPWO2019219831 A5 JP WO2019219831A5 JP 2021514483 A JP2021514483 A JP 2021514483A JP 2021514483 A JP2021514483 A JP 2021514483A JP WO2019219831 A5 JPWO2019219831 A5 JP WO2019219831A5
Authority
JP
Japan
Prior art keywords
stroke
subject
biomarkers
dusp1
adm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021514483A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021523744A (ja
JP2021523744A5 (https=
JP7463351B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/062653 external-priority patent/WO2019219831A1/en
Publication of JP2021523744A publication Critical patent/JP2021523744A/ja
Publication of JP2021523744A5 publication Critical patent/JP2021523744A5/ja
Publication of JPWO2019219831A5 publication Critical patent/JPWO2019219831A5/ja
Priority to JP2024051056A priority Critical patent/JP2024075761A/ja
Application granted granted Critical
Publication of JP7463351B2 publication Critical patent/JP7463351B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021514483A 2018-05-16 2019-05-16 脳卒中の血液バイオマーカー Active JP7463351B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024051056A JP2024075761A (ja) 2018-05-16 2024-03-27 脳卒中の血液バイオマーカー

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18305600 2018-05-16
EP18305600.1 2018-05-16
PCT/EP2019/062653 WO2019219831A1 (en) 2018-05-16 2019-05-16 Blood biomarkers of stroke

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024051056A Division JP2024075761A (ja) 2018-05-16 2024-03-27 脳卒中の血液バイオマーカー

Publications (4)

Publication Number Publication Date
JP2021523744A JP2021523744A (ja) 2021-09-09
JP2021523744A5 JP2021523744A5 (https=) 2022-05-23
JPWO2019219831A5 true JPWO2019219831A5 (https=) 2022-05-23
JP7463351B2 JP7463351B2 (ja) 2024-04-08

Family

ID=62386311

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021514483A Active JP7463351B2 (ja) 2018-05-16 2019-05-16 脳卒中の血液バイオマーカー
JP2024051056A Pending JP2024075761A (ja) 2018-05-16 2024-03-27 脳卒中の血液バイオマーカー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024051056A Pending JP2024075761A (ja) 2018-05-16 2024-03-27 脳卒中の血液バイオマーカー

Country Status (13)

Country Link
US (1) US12247257B2 (https=)
EP (1) EP3794355A1 (https=)
JP (2) JP7463351B2 (https=)
KR (1) KR20210049026A (https=)
CN (1) CN112424609A (https=)
AU (1) AU2019270404B2 (https=)
BR (1) BR112020023259A2 (https=)
CA (1) CA3100171A1 (https=)
IL (1) IL278666B2 (https=)
MA (1) MA52617A (https=)
MX (1) MX2020012297A (https=)
SG (1) SG11202011369VA (https=)
WO (1) WO2019219831A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220093267A1 (en) * 2019-01-22 2022-03-24 Arizona Board Of Regents On Behalf Of The University Of Arizona Noninvasive real-time patient-specific assessment of stroke severity
CN114107487B (zh) * 2021-12-23 2024-01-09 太原市精神病医院 一种可用于诊断脑卒中的产品
JP2023111774A (ja) * 2022-01-31 2023-08-10 国立研究開発法人国立循環器病研究センター 再灌流療法の適用を決定するバイオマーカー
CN116705296B (zh) * 2023-06-06 2024-09-13 中国科学院深圳先进技术研究院 一种基于常规mri序列对gbm患者进行风险分层的方法及系统
WO2025151599A1 (en) * 2024-01-09 2025-07-17 Morehouse School Of Medicine Rna-based method for stroke assessment and treatment

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
AU2002241520A1 (en) * 2000-11-28 2003-03-03 University Of Cincinnati Blood assessment of injury
US9005891B2 (en) 2009-11-10 2015-04-14 Genomic Health, Inc. Methods for depleting RNA from nucleic acid samples
US9410204B2 (en) 2012-01-07 2016-08-09 The Regents Of The University Of California Biomarkers for diagnosing ischemia
US20150274815A1 (en) * 2012-09-25 2015-10-01 The United States of America, as represented by the Secretary, Department of Health & Human Servic Treatment of central nervous system (cns) injury
JP2016507235A (ja) * 2013-02-01 2016-03-10 ウエストバージニア ユニバーシティＷｅｓｔ Ｖｉｒｇｉｎｉａ Ｕｎｉｖｅｒｓｉｔｙ 脳卒中症状の発症の時点を決定するためのバイオマーカーアルゴリズムおよび方法
US11021750B2 (en) * 2013-10-13 2021-06-01 The Research Foundation For State University Of Newyork Biomarkers for predicting risk of acute ischemic stroke and methods of use thereof
CN108291330A (zh) * 2015-07-10 2018-07-17 西弗吉尼亚大学 卒中和卒中严重性的标志物
US20190311789A1 (en) * 2016-10-03 2019-10-10 West Virginia University Computer implemented discovery of biomarkers for blood brain barrier disruption

Similar Documents

Publication Publication Date Title
JP2021523744A5 (https=)
IL278666B2 (en) Blood biomarkers of stroke
Carbone et al. Baseline hs‐CRP predicts hypertension remission in metabolic syndrome
Zhu et al. Cystatin C as a reliable marker of renal function following heart valve replacement surgery with cardiopulmonary bypass
Lafferty et al. The management of alcoholic hepatitis: a prospective comparison of scoring systems
CN112712896B (zh) 用于受试体检测非酒精性脂肪性肝病状态的诊断装置及计算机系统
Ji et al. Diagnostic and prognostic value of galectin‐3, serum creatinine, and cystatin C in chronic kidney diseases
JP7179356B2 (ja) 代謝物分析を利用したベーチェット病の診断方法
Gudowska et al. High serum N-terminal propeptide of procollagen type III concentration is associated with liver diseases
von Zur Mühlen et al. Urine proteome analysis as a discovery tool in patients with deep vein thrombosis and pulmonary embolism
Owen et al. Performance characteristics of an HPLC assay for urinary albumin
US20090286324A1 (en) Serum markers for type ii diabetes mellitus
JPWO2019219831A5 (https=)
Hussein et al. Evaluation of soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) and sLOX-1/oxidized LDL ratio as novel biomarkers of acute coronary syndrome
Dur et al. Oxidative status and lymphocyte DNA damage in patients with acute pancreatitis and its relationship with severity of acute pancreatitis
WANG et al. Efficacy of transient elastography in screening for large esophageal varices in patients with suspicious or proven liver cirrhosis
Liao et al. Triggering receptor in myeloid cells (TREM-1) specific expression in peripheral blood mononuclear cells of sepsis patients with acute cholangitis
RU2008103988A (ru) Способ диагностики рассеяного склероза
Shenoy et al. Utility of biochemical markers in predicting severe COVID-19: experience from a tertiary hospital in South India
Ren et al. Influence of systemic immunoinflammatory index on major adverse cardiovascular events in patients with coronary heart disease with heart failure as assessed by propensity score matching
Celik et al. The relationship between platelet indices and ABO blood groups in healthy adults
Benbow et al. Analysis of plasma tenascin-C in post-HCV cirrhosis: a prospective study
NO20062280L (no) Test
Olut et al. Seroprevalence of hepatitis C virus infection and evaluation of serum aminotransferase levels among haemodialysis patients in Izmir, Turkey
JP2015068760A (ja) 好酸球性気道炎症に関する情報の取得方法およびそのような情報を取得するためのマーカー